The following were selected from among 80 abstracts for oral presentation during the 3rd Annual ENETS Conference held in Prague in March 2006. The authors in bold were awarded monetary prizes during the conference:

Clinical Research

David Gross et al, Jerusalem, Israel. The role of imatinib mesylate (Glivec®) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R Jeanette Mares et al, Houston, TX, USA. Association between tobacco usage with an increased risk of pulmonary carcinoids Sergio Pedrazzoli et al, Padua, Italy. Enucleation of endocrine pancreatic tumors: A 25-year experience. Christos Toumpanakis et al, London, United Kingdom. Goblet cell carcinoid tumours (adenocarcinoid) Frederic Triponez et al, Geneva, Switzerland. General and endocrine surgery, Switzerland. Is surgery beneficial for MEN1 patients with non-functioning tumor(s) of the pancreas of less than 2 cm? An analysis of 65 patients from the French study group of MEN1 (GTE) Richard Warner et al, New York, New York, USA. The capsule is useful in identifying obscure primary carcinoids in the small intestine

Basic Research

Christian Arnold et al, Marburg, Germany. Inactivation of differential tumor suppressor genes in neuroendocrine tumors of the gastrointestinal tract Yuan-Jia Chen et al, Beijing, China. Genetic and epigenetic inactivation of mismatch repair gene hMLH1 in tumorigenesis of sporadic insulinomas Viktor Johanson et al, Gothenborg, Sweden. Potent antitumour activity of CHS 828 on xenografted human neuroendocrine tumours in nude mice Yvonne Jonkers et al, Maastricht, The Netherlands. Frequent loss of chromosome 11q and 22q in insulinomas Virginia Kostoula et al, London, Great Britain. Effect of cisplatin and ionizing radiation on EGFR signaling in neuroendocrine tumour cell lines